Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Potent and highly selective CCK-A antagonist designed by Tobishi

Nov. 26, 1998

New compounds for immunoinflammatory and neoplastic diseases in the pipeline at Ferring

Nov. 26, 1998

Shearwater Polymers will pegylate interferon alfa-2a for Roche under new agreement

Nov. 26, 1998

Major clinical trials demonstrate efficacy of Rebetron in chronic HCV infection

Nov. 23, 1998

Anti-H. pylori cephems in development at Takeda

Nov. 19, 1998

Lamivudine highlighted at recent Study for Liver Diseases meeting

Nov. 18, 1998

Triangle Pharmaceuticals presents preliminary data on FTC in HBV patients

Nov. 18, 1998

Study completed on new therapy for traveler's diarrhea

Nov. 18, 1998

Gilead's adefovir dipivoxil extensively covered at AASLD meeting

Nov. 17, 1998

Pegylated interferon proves superior to standard interferon for treatment of HCV

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...